Saint Louis University Health Sciences Center
St Louis, Missouri, 63110-0250, United States
NCT Number: NCT00032708
A double-blind, randomized, dose-response study of four dilutions of Dryvax in previously vaccinated adults in order to assess the clinical success rates, humoral responses, and virus-specific actifity of cytotoxi T cells and interferon-y producing T cells
Looking for future studies?
Notify MeInterventional
Phase 2
St Louis, Missouri, 63110-0250, United States
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Institute of Allergy and Infectious Diseases (NIAID)
Nih
A Double Blind, Randomized Dose Response Study of Dryvax Vaccine Against Smallpox in Previously Vaccinated Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00437021
DNA Virus Infections, Infections
Iowa City, Iowa, United States
View Trial DetailsNCT05995275
Animal Diseases, DNA Virus Infections
Bradford, United Kingdom
View Trial DetailsNCT00879762
DNA Virus Infections, Infections
Iowa City, Iowa, United States
View Trial DetailsNCT05935917
DNA Virus Infections, Infections
Overland Park, Kansas, United States
View Trial Details